EverydayHealthLogo
Dr. Yoon-Jae Cho, MD

Dr. Yoon-Jae Cho, MD

Portland, OR

17 Years of Experience

Accepting patients

    Who is Dr. Cho, Pediatric Neurologist in Portland, OR?

    Dr. Yoon-Jae Cho, MD is a Pediatric Neurologist, who primarily practices in Portland, OR. He has been practicing for over 17 years and is board certified by the American Board of Psychiatry and Neurology. Dr. Cho is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Cho’s office at (503) 494-5856.

    Where did Dr. Cho go to medical school and complete their residency?

    • Fellowship: Children's Hospital Boston, Boston, MA | Children's Hospital Boston MA

    Is Dr. Cho board certified in Pediatric Neurologist?

    Yes, Dr. Yoon-Jae Cho, MD is board certified by the American Board of Psychiatry and Neurology since 2009

    What languages does Dr. Cho speak?

    Dr. Cho and their clinical team can communicate with patients in the following languages:

    • English

    Does Dr. Cho accept my insurance?

    Dr. Cho accepts most major insurance plans. Important: Please call our office at (503) 494-5856 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Cho accept in Portland, OR?

    Dr. Cho in Portland, OR accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Cross Blue Shield of Massachusetts

    • Molina

    View All Insurances

    Where is Dr. Cho's office located?

    Dr. Yoon-Jae Cho's Primary Practice

    3181 SW Sam Jackson Park Rd

    Portland, OR 97239

    (503) 494-5856

    Get Directions

    Recognitions

    Awards

    Faculty Development Award, Shore Fellowship Program for Scholars in Me

    Young Investigator Award, Pediatric Brain Tumor Foundation

    Laurel MD-PhD Scholar, Oregon Medical Research Foundation

    Biology Committee, Pediatric Brain Tumor Consortium

    Philip R. Dodge Young Investigator Award, Child Neurology Society

    Beirne Faculty Scholar in Pediatirc Neuro-oncology, Stanford Universi

    Scholar, St. Baldrick's Foundation

    Publications

    Epigenetic targeting of Hedgehog pathway transcriptiol output through BET bromodomain inhibition.

    ture medicine, 2014

    Reduced H3K27me3 and D Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant

    Cancer cell, 2013

    Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

    TURE, 2012

    Integrative Genomic Alysis of Medullobl

    JOURL OF CLINICAL ONCOLOGY, 2011

    alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth

    ACTA NEUROPATHOLOGICA, 2014

    Cytogenetic Prognostication Within Medulloblastoma Subgroups

    JOURL OF CLINICAL ONCOLOGY, 2014

    Genome Sequencing of SHH Medulloblastoma Predicts Genotype

    CANCER CELL, 2014

    Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct

    Jourl of neuro-oncology, 2014

    BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma.

    Clinical cancer research, 2014

    Medulloblastoma Down Under 2013

    ACTA NEUROPATHOLOGICA, 2014

    TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.

    Acta neuropathologica, 2013

    Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular alysis.

    lancet oncology, 2013

    Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.

    Jourl of clinical oncology, 2013

    Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

    ture genetics, 2013

    BAF complexes facilitate decatetion of D by topoisomerase IIa.

    ture, 2013

    Genomic alysis of diffuse pediatric low

    Proceedings of the tiol Academy of Sciences of the United States of Am, 2013

    Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene

    MOLECULAR CANCER RESEARCH, 2013

    Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 sigling

    MOLECULAR CANCER, 2013

    Activation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5.

    Oncogene

    The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward

    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012

    Medulloblastomics: the end of the beginning

    TURE REVIEWS CANCER, 2012

    Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    TURE, 2012

    Dissecting the genomic complexity underlying medulloblastoma

    TURE, 2012

    Epigenetic ictivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors

    CELL CYCLE, 2012

    Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras

    PLOS GENETICS, 2012

    Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

    ACTA NEUROPATHOLOGICA, 2012

    Molecular subgroups of medulloblastoma

    ACTA NEUROPATHOLOGICA, 2012

    MicroR-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma

    ACTA NEUROPATHOLOGICA, 2012

    Pleiotropic effects of miR-183 similar to 96 similar to 182 converge to regulate cell survival

    ACTA NEUROPATHOLOGICA, 2012

    Molecular subgroups of medulloblastoma: the current consensus

    ACTA NEUROPATHOLOGICA, 2012

    Biological and clinical heterogeneity of MYCN-amplified medulloblastoma

    ACTA NEUROPATHOLOGICA, 2012

    Clol selection drives genetic divergence of metastatic medulloblastoma

    TURE, 2012

    An Animal Model of MYC-Driven Medulloblastoma

    CANCER CELL, 2012

    Expression of FoxM1 is required for the proliferation of medulloblastoma cells

    Clinical cancer research, 2011

    Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

    CANCER CELL, 2011

    Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical

    JOURL OF CLINICAL ONCOLOGY, 2011

    Molecular fingerprints of medulloblastoma and their application to clinical practice

    FUTURE ONCOLOGY, 2011

    miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

    NEURO-ONCOLOGY, 2011

    Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

    TURE COMMUNICATIONS, 2011

    Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway

    TURE MEDICINE, 2010

    Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma

    NEURO-ONCOLOGY, 2010

    Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation

    CANCER CELL, 2010

    The landscape of somatic copy-number alteration across human cancers

    TURE, 2010

    MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA

    NEUROLOGY, 2009

    Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability

    MOLECULAR AND CELLULAR BIOLOGY, 2008

    What is Dr. Cho's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Cho's National Provider Identifier (NPI) number is 1083804181.

    What common questions do patients ask about Dr. Cho?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Cho

    What is Dr. Yoon-Jae Cho's specialty?

    Dr. Cho is a Pediatric Neurologist near Portland, OR. A Child Neurologist specializes in diagnosing and treating neurological disorders in newborns, infants, young children, and adolescents, with expertise in managing conditions specific to these developmental stages. Contact Dr. Cho to book an appointment today.

    Is this Dr. Yoon-Jae Cho affiliated with a ranked Castle Connolly Top Hospital?

    No, Cho is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Pediatric Neurologist?

    Explore Pediatric Neurologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Yoon-Jae Cho accepting new patients in Portland, OR?

    Yes, Dr. Yoon-Jae Cho is accepting new patients at this time.

    Does Dr. Yoon-Jae Cho offer online booking?

    Please contact Dr. Cho's office at (503) 494-5856 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Yoon-Jae Cho?

    Please contact Dr. Cho's office at (503) 494-5856 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Yoon-Jae Cho have?

    Dr. Yoon-Jae Cho is certified by the American Board of Psychiatry and Neurology.

    Other Pediatric Neurologist Near Portland, OR

    AR

    Pediatric Neurologist

    acceptingPatients-iconAccepting patients
    Portland, OR
    MP

    Pediatric Neurologist

    acceptingPatients-iconAccepting patients
    Portland, OR
    DC

    Pediatric Neurodevelopmental Disabilities Specialist

    acceptingPatients-iconAccepting patients
    Portland, OR
    See All Specialists

    Doctors by Category

    Specialists